PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Sol-Gel Nose-to-Brain Delivery System of Cannabinoids
Universally-patient friendly, meaning formulations that can be used in children and adults alike Transport of drugs through blood-brain barrier marks top priority for researchers North American legal cannabis market projected at more than $24 billion by 2021 Global market for pain management, drugs and devices estimated at over $61 billion by 2023 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is a Vancouver-based health sciences company dedicated to research and development of innovative, organic and Nature Identical™ options for preventive and curative therapies for a wide array of devastating medical conditions. Developing what the company believes will be the…